SeaStar Medical Holding Corp is a commercial-stage healthcare company focused on developing transformational treatments for critically ill patients facing organ failure. Its Selective Cytopheretic Device (SCD) is designed to neutralize overactive immune cells and has applications in acute and chronic kidney disease, as well as cardiovascular and inflammatory diseases.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.